Skip to main content

Travere Therapeutics, Inc 10-Q for FY2024 Q3

Travere Therapeutics, Inc. (TVTX)

10-Q 2024-10-31 For: 2024-09-30
View Original
Added on April 07, 2026

About this 10-Q

Travere Therapeutics, Inc filed this 10-Q on October 31, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$62.9M
up 69.6% from $37.1M a year earlier
Net loss
$54.81M
compared with net income of $150.74M a year earlier
Diluted EPS
-$0.70
compared with $1.97 a year earlier